The 2022 Banff Meeting Lung Report

• DOI: 10.1016/j.ajt.2023.10.022
• Publication Date: 2023-11-04T08:52:33Z
• Authors: Elizabeth N. Pavl...; Benjamin A. Adam; Gerald J. Berry; Fiorella Calabrese; Nahir Cortes-Sant...; Carolyn H. Glass; Martin Goddard; John R. Greenland; Daniel Kreisel; Deborah J. Levine; Tereza Martinu; Stijn E. Verleden; S. Sam Weigt; Antoine Roux
• Keywords: [SDV] Life Sciences [q-bio]; [SDV]Life Sciences [q-bio]; lung transplantation; 610; pathology; molecular; [SHS] Humanities and Social Sciences; Human medicine; artificial intelligence; artificial intelligence; lung transplantation; molecular; pathology; 3. Good health; [SHS]Humanities and Social Sciences

The Lung Session of the 2022 16th Banff Foundation for Allograft Pathology Conference-held in Banff, Alberta-focused on non-rejection lung allograft pathology and novel technologies detection injury. A multidisciplinary panel reviewed state-of-the-art current histopathologic entities, serologic studies, molecular practices, as well applications digital with artificial intelligence, gene expression analysis, quantitative image analysis chest computerized tomography. Current states need prospective integration aforementioned tools complete assessment injury its impact transplant outcomes were discussed. Key conclusions from discussion were: (1) recognition limitations standard care dysfunction; (2) agreement a consensus regarding standardized approach to collection pathologic data, inclusive all lesions associated graft outcome (eg, pathology); (3) optimism promising diagnostic modalities, especially minimally invasive, which should be integrated into large, multicenter studies further evaluate their utility clinical practice directing personalized therapies improve outcomes.